North America Bioprocess Technology Market Outlook, 2030

The North America Bioprocess Technology Market is estimated at USD 79 billion in 2032, driven by rising demand for treatments of chronic diseases.

According to publisher, Here is the North American Bioprocess Technology Market Report

Market Insights
The North American bioprocess technology market is a thriving sector poised for significant growth. Estimates suggest the market will reach USD 79 billion by 2032, driven by a robust biopharmaceutical industry and rising demand for treatments of chronic diseases. The aging population and growing prevalence of conditions like diabetes and cardiovascular diseases are fueling the need for advanced biotechnologies.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


Market Dynamics
Several factors are propelling the North American bioprocess technology market:
Development in the Biopharmaceutical Industry: The biopharmaceutical industry is heavily reliant on bioprocess technologies for the development and production of life-saving drugs and therapies. The increasing focus on personalized medicine and biologics further intensifies this dependence.
Growing Demand for Biologic Drugs: Biologic drugs, derived from living organisms, are demonstrating immense potential in treating complex diseases. This surging demand necessitates advancements in bioprocess technology for efficient and cost-effective production.
Technological Advancements: Continuous innovation in areas like single-use bioprocessing systems, bioinformatics, and automation is streamlining biomanufacturing processes, leading to increased efficiency and productivity.

Market Segments
The North American bioprocess technology market can be segmented by:
Product Type:
Cell Culture Media: This segment holds a significant share due to its vital role in cultivating cells for various bioprocesses.
Chromatography Bioprocess: This segment is experiencing rapid growth as it enables efficient purification of bioproducts.
Consumables & Accessories: This segment encompasses filters, bioreactors, and other essential tools used throughout bioprocessing.
Modality:
Single-Use Technologies: This segment is gaining traction due to its disposable nature, eliminating cleaning and validation needs.
Multi-Use Technologies: This established segment offers reusability but requires cleaning and validation procedures.
End User:
Biopharmaceutical Companies: These companies are the primary drivers of the market, demanding advanced technologies for large-scale biomanufacturing.
Academic & Medical Institutions: Research activities and clinical trials drive demand for bioprocess technology in these institutions.
Research Laboratories: These entities utilize bioprocess technology for discovery and development of novel therapeutics.

Regional Analysis
North America dominates the global bioprocess technology market, holding over 40% of the revenue share. The United States is the region's leader, accounting for nearly 89% of the North American market value. This dominance is attributed to factors like:
Strong presence of leading biopharmaceutical companies like Amgen and Merck.
Government funding for research and development in life sciences.
High healthcare spending and increasing adoption of advanced medical therapies.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant



Key Developments
The North American bioprocess technology market is witnessing continuous advancements. Some examples include:
Mergers and acquisitions between bioprocess technology companies to expand product portfolios and geographical reach.
Increased investments in R&D for developing novel biomanufacturing technologies.
Growing adoption of automation and digitalization solutions to optimize bioprocesses.

Competitive Landscape
The North American bioprocess technology market is a competitive landscape with established players and emerging companies vying for market share. Key players include:
Thermo Fisher Scientific
Merck KGaA
Danaher Corporation (Pall Corporation)
Sartorius Stedim Biotech
GE Healthcare

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Table of Contents

  • 1 Introduction 7
  • 1.1 Industry Definition and Research Scope 7
  • 1.1.1 Industry Definition 7
  • 1.1.2 Research Scope 8
  • 1.2 Research Methodology 11
  • 1.2.1 Overview of Market Research Methodology 11
  • 1.2.2 Market Assumption 12
  • 1.2.3 Secondary Data 12
  • 1.2.4 Primary Data 12
  • 1.2.5 Data Filtration and Model Design 13
  • 1.2.6 Market Size/Share Estimation 14
  • 1.2.7 Research Limitations 15
  • 1.3 Executive Summary 16
  • 2 Market Overview and Dynamics 19
  • 2.1 Market Size and Forecast 19
  • 2.1.1 Impact of COVID-19 on World Economy 20
  • 2.1.2 Impact of COVID-19 on the Market 24
  • 2.1.3 Impact of Russia-Ukraine Conflict 26
  • 2.1.4 Impact of Israel-Palestine War 28
  • 2.2 Major Growth Drivers 29
  • 2.3 Market Restraints and Challenges 34
  • 2.4 Emerging Opportunities and Market Trends 37
  • 2.5 Porter’s Fiver Forces Analysis 41
  • 3 Segmentation of North America Market by Product 45
  • 3.1 Market Overview by Product 45
  • 3.2 Instruments 47
  • 3.2.1 Bioprocess Analyzers 49
  • 3.2.2 Osmometers 50
  • 3.2.3 Bioreactors 51
  • 3.2.4 Incubators 52
  • 3.2.5 Other Instruments 53
  • 3.3 Consumables and Accessories 54
  • 3.3.1 Culture Media 56
  • 3.3.2 Reagents 57
  • 3.3.3 Other Consumables and Accessories 58
  • 4 Segmentation of North America Market by Process 59
  • 4.1 Market Overview by Process 59
  • 4.2 Upstream Bioprocessing 61
  • 4.3 Downstream Bioprocessing 62
  • 5 Segmentation of North America Market by Procedure 63
  • 5.1 Market Overview by Procedure 63
  • 5.2 Cell Culture 65
  • 5.3 Cell Expansion 66
  • 5.4 Flow Cytometry 67
  • 5.5 Cell Line Development 68
  • 5.6 Cell Counting 69
  • 5.7 Biologics Safety Testing 70
  • 5.8 Tangential Flow Filtration (TFF) 71
  • 5.9 Other Procedures 72
  • 6 Segmentation of North America Market by Application 73
  • 6.1 Market Overview by Application 73
  • 6.2 Recombinant Proteins 75
  • 6.3 Antibiotics 76
  • 6.4 Biosimilars 77
  • 6.5 Monoclonal Antibodies (mAbs) 78
  • 6.6 Other Applications 79
  • 7 Segmentation of North America Market by End User 80
  • 7.1 Market Overview by End User 80
  • 7.2 Biopharmaceutical Companies 82
  • 7.3 Contract Manufacturing Organizations (CMOs) 83
  • 7.4 Academic Research Institutes 84
  • 7.5 Contract Research Organizations (CROs) 85
  • 7.6 Food & Feed Industry 86
  • 7.7 Other End Users 87
  • 8 North America Market 2023-2033 by Country 88
  • 8.1 Overview of North America Market 88
  • 8.2 U.S. 91
  • 8.3 Canada 94
  • 8.4 Mexico 96
  • 9 Competitive Landscape 98
  • 9.1 Overview of Key Vendors 98
  • 9.2 New Product Launch, Partnership, Investment, and M&A 102
  • 9.3 Company Profiles 103
  • Advanced Instruments LLC 103
  • Agilent Technologies, Inc. 105
  • Becton Dickinson and Company 106
  • Bio-rad Laboratories Inc. 107
  • Boehringer Ingelheim International GmbH 108
  • Catalent Inc. 109
  • Charles River Laboratories 110
  • Corning Inc. 111
  • Danaher Corporation 112
  • Elitechgroup Inc. (gonotec Gmbh) 113
  • Eppendorf Se 114
  • F. Hoffmann-la Roche Ltd. 115
  • Fujifilm Healthcare Americas Corporation 116
  • GE Healthcare (General Electric Company) 117
  • Getinge Ab 118
  • Koninklijke Philips N.V. 119
  • Lonza Group Ag 120
  • Merck Kgaa 121
  • Repligen Corp. 122
  • Sartorius Group 123
  • STADA Arzneimittel AG 124
  • Thermo Fisher Scientific Inc. 125
  • RELATED REPORTS 126



Table 1. Snapshot of North America Bioprocess Technology Market in Balanced Perspective, 2023-2033 17
Table 2. World Economic Outlook, 2024-2036 21
Table 3. World Economic Outlook, 2022-2024 23
Table 4. Scenarios for Economic Impact of Ukraine Crisis 27
Table 5. Scenarios for Economic Impact of Israel-Palestine War 28
Table 6. Estimated Worldwide Spending on Biopharmaceutical R&D, 2015-2023, $ billion 32
Table 7. World Health Spending by Region, $ bn, 2013-2020 33
Table 8. Main Product Trends and Market Opportunities in North America Bioprocess Technology Market 37
Table 9. North America Bioprocess Technology Market by Product, 2023-2033, $ mn 45
Table 10. North America Bioprocess Technology Market: Instruments by Type, 2023-2033, $ mn 48
Table 11. North America Bioprocess Technology Market: Consumables and Accessories by Type, 2023-2033, $ mn 55
Table 12. North America Bioprocess Technology Market by Process, 2023-2033, $ mn 59
Table 13. North America Bioprocess Technology Market by Procedure, 2023-2033, $ mn 63
Table 14. North America Bioprocess Technology Market by Application, 2023-2033, $ mn 73
Table 15. North America Bioprocess Technology Market by End User, 2023-2033, $ mn 80
Table 16. North America Bioprocess Technology Market by Country, 2023-2033, $ mn 89
Table 17. U.S. Bioprocess Technology Market by Product, 2023-2033, $ mn 93
Table 18. U.S. Bioprocess Technology Market by Application, 2023-2033, $ mn 93
Table 19. U.S. Bioprocess Technology Market by End User, 2023-2033, $ mn 93
Table 20. Canada Bioprocess Technology Market by Product, 2023-2033, $ mn 95
Table 21. Canada Bioprocess Technology Market by Application, 2023-2033, $ mn 95
Table 22. Canada Bioprocess Technology Market by End User, 2023-2033, $ mn 95
Table 23. Mexico Bioprocess Technology Market by Product, 2023-2033, $ mn 97
Table 24. Mexico Bioprocess Technology Market by Application, 2023-2033, $ mn 97
Table 25. Mexico Bioprocess Technology Market by End User, 2023-2033, $ mn 97
Table 26. Key Vendors and Their Product Offerings 100
Table 27. Advanced Instruments LLC: Company Snapshot 103
Table 28. Advanced Instruments LLC: Business Segmentation 104
Table 29. Advanced Instruments LLC: Product Portfolio 104



Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 16
Figure 4. North America Bioprocess Technology Market, 2023-2033, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of North America Bioprocess Technology Market 29
Figure 7. World Population 65 and Over, % of Total Population, 1950-2060 32
Figure 8. Primary Restraints and Impact Factors of North America Bioprocess Technology Market 34
Figure 9. Investment Opportunity Analysis 38
Figure 10. Porter’s Fiver Forces Analysis of North America Bioprocess Technology Market 41
Figure 11. Breakdown of North America Bioprocess Technology Market by Product, 2023-2033, % of Revenue 46
Figure 12. North America Addressable Market Cap in 2024-2033 by Product, Value ($ mn) and Share (%) 46
Figure 13. North America Bioprocess Technology Market by Product: Instruments, 2023-2033, $ mn 47
Figure 14. North America Bioprocess Technology Market by Instruments: Bioprocess Analyzers, 2023-2033, $ mn 49
Figure 15. North America Bioprocess Technology Market by Instruments: Osmometers, 2023-2033, $ mn 50
Figure 16. North America Bioprocess Technology Market by Instruments: Bioreactors, 2023-2033, $ mn 51
Figure 17. North America Bioprocess Technology Market by Instruments: Incubators, 2023-2033, $ mn 52
Figure 18. North America Bioprocess Technology Market by Instruments: Other Instruments, 2023-2033, $ mn 53
Figure 19. North America Bioprocess Technology Market by Product: Consumables and Accessories, 2023-2033, $ mn 54
Figure 20. North America Bioprocess Technology Market by Consumables and Accessories: Culture Media, 2023-2033, $ mn 56
Figure 21. North America Bioprocess Technology Market by Consumables and Accessories: Reagents, 2023-2033, $ mn 57
Figure 22. North America Bioprocess Technology Market by Consumables and Accessories: Other Consumables and Accessories, 2023-2033, $ mn 58
Figure 23. Breakdown of North America Bioprocess Technology Market by Process, 2023-2033, % of Sales Revenue 60
Figure 24. North America Addressable Market Cap in 2024-2033 by Process, Value ($ mn) and Share (%) 60
Figure 25. North America Bioprocess Technology Market by Process: Upstream Bioprocessing, 2023-2033, $ mn 61
Figure 26. North America Bioprocess Technology Market by Process: Downstream Bioprocessing, 2023-2033, $ mn 62
Figure 27. Breakdown of North America Bioprocess Technology Market by Procedure, 2023-2033, % of Sales Revenue 64
Figure 28. North America Addressable Market Cap in 2024-2033 by Procedure, Value ($ mn) and Share (%) 64
Figure 29. North America Bioprocess Technology Market by Procedure: Cell Culture, 2023-2033, $ mn 65
Figure 30. North America Bioprocess Technology Market by Procedure: Cell Expansion, 2023-2033, $ mn 66
Figure 31. North America Bioprocess Technology Market by Procedure: Flow Cytometry, 2023-2033, $ mn 67
Figure 32. North America Bioprocess Technology Market by Procedure: Cell Line Development, 2023-2033, $ mn 68
Figure 33. North America Bioprocess Technology Market by Procedure: Cell Counting, 2023-2033, $ mn 69
Figure 34. North America Bioprocess Technology Market by Procedure: Biologics Safety Testing, 2023-2033, $ mn 70
Figure 35. North America Bioprocess Technology Market by Procedure: Tangential Flow Filtration (TFF), 2023-2033, $ mn 71
Figure 36. North America Bioprocess Technology Market by Procedure: Other Procedures, 2023-2033, $ mn 72
Figure 37. Breakdown of North America Bioprocess Technology Market by Application, 2023-2033, % of Revenue 74
Figure 38. North America Addressable Market Cap in 2024-2033 by Application, Value ($ mn) and Share (%) 74
Figure 39. North America Bioprocess Technology Market by Application: Recombinant Proteins, 2023-2033, $ mn 75
Figure 40. North America Bioprocess Technology Market by Application: Antibiotics, 2023-2033, $ mn 76
Figure 41. North America Bioprocess Technology Market by Application: Biosimilars, 2023-2033, $ mn 77
Figure 42. North America Bioprocess Technology Market by Application: Monoclonal Antibodies (mAbs), 2023-2033, $ mn 78
Figure 43. North America Bioprocess Technology Market by Application: Other Applications, 2023-2033, $ mn 79
Figure 44. Breakdown of North America Bioprocess Technology Market by End User, 2023-2033, % of Revenue 81
Figure 45. North America Addressable Market Cap in 2024-2033 by End User, Value ($ mn) and Share (%) 81
Figure 46. North America Bioprocess Technology Market by End User: Biopharmaceutical Companies, 2023-2033, $ mn 82
Figure 47. North America Bioprocess Technology Market by End User: Contract Manufacturing Organizations (CMOs), 2023-2033, $ mn 83
Figure 48. North America Bioprocess Technology Market by End User: Academic Research Institutes, 2023-2033, $ mn 84
Figure 49. North America Bioprocess Technology Market by End User: Contract Research Organizations (CROs), 2023-2033, $ mn 85
Figure 50. North America Bioprocess Technology Market by End User: Food & Feed Industry, 2023-2033, $ mn 86
Figure 51. North America Bioprocess Technology Market by End User: Other End Users, 2023-2033, $ mn 87
Figure 52. Breakdown of North America Bioprocess Technology Market by Country, 2023 and 2033, % of Revenue 89
Figure 53. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 90
Figure 54. U.S. Bioprocess Technology Market, 2023-2033, $ mn 92
Figure 55. Canada Bioprocess Technology Market, 2023-2033, $ mn 94
Figure 56. Bioprocess Technology Market in Mexico, 2023-2033, $ mn 96
Figure 57. Growth Stage of North America Bioprocess Technology Industry over the Forecast Period 98
Logo

North America Bioprocess Technology Market Outlook, 2030

Contact usWe are friendly and approachable, give us a call.